GHRP-2

Approved source records

1. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.

   DOI: 10.21037/tau.2019.11.30PMID: 32257855

   Source identity and connection checked by Codex (AI).

2. Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.

   Yasufumi Seki; Atsuhiro Ichihara · PloS one · 2022

   DOI: 10.1210/jcem.77.3.8103770PMID: 35452483

3. Determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using HPLC-MS/MS and its application to a pharmacokinetic study.

   Natalia E Moskaleva; Pavel A Markin; Roman M Kuznetsov; Tatiana M Andronova; Svetlana A Appolonova · Biomedical chromatography : BMC · 2020

   DOI: 10.1002/bmc.4948PMID: 32652605

4. Detection of black market follistatin 344.

   Christian Reichel; Günter Gmeiner; Mario Thevis · Drug testing and analysis · 2019

   DOI: 10.1002/dta.2741PMID: 31758732

5. Glycine-modified growth hormone secretagogues identified in seized doping material.

   Paulina Marta Gajda; Niels Bjerre Holm; Lars Jakobsen Hoej; Brian Schou Rasmussen; Petur Weihe Dalsgaard; Lotte Ask Reitzel; Kristian Linnet · Drug testing and analysis · 2019

   DOI: 10.1002/dta.2489PMID: 30136411

6. Analysis of new growth promoting black market products.

   Oliver Krug; Andreas Thomas; Helle Malerød-Fjeld; Yvette Dehnes; Tim Laussmann; Ingo Feldmann; Albert Sickmann; Mario Thevis · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2018

   DOI: 10.1016/j.ghir.2018.05.001PMID: 29864719

7. Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.

   Kazunori Kageyama; Satoru Sakihara; Wataru Kameda; Aya Sugiyama; Shinobu Takayasu; Ken Terui; Makoto Daimon · Endocrine journal · 2018

   DOI: 10.1507/endocrj.EJ17-0527PMID: 29973439

8. Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.

   John T Sigalos; Alexander W Pastuszak; Andrew Allison; Samuel J Ohlander; Amin Herati; Mark C Lindgren; Larry I Lipshultz · American journal of men's health · 2017

   DOI: 10.1385/endo:22:1:25PMID: 28830317

9. Structure-activity relationship for peptídic growth hormone secretagogues.

   P Ferro; G Krotov; I Zvereva; G Rodchenkov; J Segura · Drug testing and analysis · 2017

   DOI: 10.1002/dta.1947PMID: 26811125

10. Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells.

    Yi-Ning Chao; David Sun; Yen-Chun Peng; Yuh-Lin Wu · International journal of molecular sciences · 2016

    DOI: 10.1074/jbc.270.42.24965PMID: 27548147

11. Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.

    Xiaoyu Hu; Beihua Xu; Ziniu Zhou · AAPS PharmSciTech · 2015

    DOI: 10.1007/s12272-010-0718-zPMID: 25761386

12. Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat.

    Xiyao Zhang; Wensong Li; Ping Li; Manli Chang; Xu Huang; Qiang Li; Can Cui · BioMed research international · 2014

    DOI: 10.1155/2014/923564PMID: 25247193

13. Metabolism of growth hormone releasing peptides.

    Andreas Thomas; Philippe Delahaut; Oliver Krug; Wilhelm Schänzer; Mario Thevis · Analytical chemistry · 2012

    DOI: 10.1021/ac302034wPMID: 23101768

14. Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary.

    Kazunori Kageyama; Mihoko Kushibiki; Komaki Hanada; Satoru Sakihara; Minoru Yasujima; Toshihiro Suda · Regulatory peptides · 2009

    DOI: 10.1016/j.regpep.2009.07.018PMID: 19682503

15. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.

    Kazuo Chihara; Akira Shimatsu; Naomi Hizuka; Toshiaki Tanaka; Yoshiki Seino; Yuzuru Katofor; KP-102 Study Group · European journal of endocrinology · 2007

    DOI: 10.1530/EJE-07-0066PMID: 17609397

16. KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts.

    Sadayoshi Furuta; Toshimitsu Hori; Tadashi Ohyama · Naunyn-Schmiedeberg's archives of pharmacology · 2006

    DOI: 10.1007/s00210-006-0079-9PMID: 16773386

17. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.

    Chiharu Hirotani; Yutaka Oki; Kiyoharu Ukai; Tadashi Okuno; Shigeru Kurasaki; Tadashi Ohyama; Naomi Doi; Ken Sasaki; Katsuhiko Ase · Naunyn-Schmiedeberg's archives of pharmacology · 2005

    DOI: 10.1007/s00210-004-1009-3PMID: 15645295

18. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.

    Blandine Laferrère; Cynthia Abraham; Colleen D Russell; Cyril Y Bowers · The Journal of clinical endocrinology and metabolism · 2005

    DOI: 10.1210/jc.2004-1719PMID: 15699539

19. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

    Sadayoshi Furuta; Osafumi Shimada; Naomi Doi; Kiyoharu Ukai; Terutake Nakagawa; Jyo Watanabe; Masakazu Imaizumi · Arzneimittel-Forschung · 2004

    DOI: 10.1055/s-0031-1297042PMID: 15646371

20. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

    Naomi Doi; Chiharu Hirotani; Kiyoharu Ukai; Osafumi Shimada; Tadashi Okuno; Shigeru Kurasaki; Takeshi Kiyofuji; Reiko Ikegami; Machiko Futamata; Terutake Nakagawa; Katsuhiko Ase; Kazuo Chihara · Arzneimittel-Forschung · 2004

    DOI: 10.1055/s-0031-1297041PMID: 15646370

21. Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

    Drugs in R&D · 2004

    DOI: 10.2165/00126839-200405040-00011PMID: 15230633

22. The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus).

    B S Shepherd; S M Eckert; I S Parhar; M M Vijayan; I Wakabayashi; T Hirano; E G Grau; T T Chen · The Journal of endocrinology · 2000

    DOI: 10.1677/joe.0.167r007PMID: 11115782

23. Ipamorelin, the first selective growth hormone secretagogue.

    K Raun; B S Hansen; N L Johansen; H Thøgersen; K Madsen; M Ankersen; P H Andersen · European journal of endocrinology · 1998

    DOI: 10.1530/eje.0.1390552PMID: 9849822

24. Growth hormone-releasing peptides.

    E Ghigo; E Arvat; G Muccioli; F Camanni · European journal of endocrinology · 1997

    DOI: 10.1530/eje.0.1360445PMID: 9186261

25. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

    G Van den Berghe; F de Zegher; C Y Bowers; P Wouters; P Muller; F Soetens; D Vlasselaers; M Schetz; C Verwaest; P Lauwers; R Bouillon · Clinical endocrinology · 1996

    DOI: 10.1046/j.1365-2265.1996.00805.xPMID: 8949573

26. GH releasing peptides--structure and kinetics.

    C Y Bowers · The Journal of pediatric endocrinology · 1993

    DOI: 10.1515/jpem.1993.6.1.21PMID: 8374685